PandemieGrippaleV1, PubMed, Curation, bibRecord, 000213

Estimating Weekly Call Volume to a National Nurse Telephone Triage Line in an Influenza Pandemic.

Identifieur interne : 000213 ( PubMed/Curation ); précédent : 000212; suivant : 000214

Estimating Weekly Call Volume to a National Nurse Telephone Triage Line in an Influenza Pandemic.

Auteurs : Bishwa B. Adhikari [États-Unis] ; Lisa M. Koonin [États-Unis] ; Melissa L. Mugambi [États-Unis] ; Kellye D. Sliger [États-Unis] ; Michael L. Washington [États-Unis] ; Emily B. Kahn [États-Unis] ; Martin I. Meltzer [États-Unis]

Source :

Health security [ 2326-5108 ]

RBID : pubmed:30339099

Descripteurs français

KwdFr :
- Grippe humaine (épidémiologie), Humains, Modèles statistiques, Pandémies, Rôle de l'infirmier, Triage (), Téléphone ().
MESH :
- épidémiologie : Grippe humaine.
- Humains, Modèles statistiques, Pandémies, Rôle de l'infirmier, Triage, Téléphone.

English descriptors

KwdEn :
- Humans, Influenza, Human (epidemiology), Models, Statistical, Nurse's Role, Pandemics, Telephone (statistics & numerical data), Triage (methods), Triage (statistics & numerical data).
MESH :
- epidemiology : Influenza, Human.
- methods : Triage.
- statistics & numerical data : Telephone, Triage.
- Humans, Models, Statistical, Nurse's Role, Pandemics.

Abstract

Telephone nurse triage lines, such as the Centers for Disease Control and Prevention's (CDC) Flu on Call^®, a national nurse triage line, may help reduce the surge in demand for health care during an influenza pandemic by triaging callers, providing advice about clinical care and information about the pandemic, and providing access to prescription antiviral medication. We developed a Call Volume Projection Tool to estimate national call volume to Flu on Call^® during an influenza pandemic. The tool incorporates 2 influenza clinical attack rates (20% and 30%), 4 different levels of pandemic severity, and different initial "seed numbers" of cases (10 or 100), and it allows variation in which week the nurse triage line opens. The tool calculates call volume by using call-to-hospitalization ratios based on pandemic severity. We derived data on nurse triage line calls and call-to-hospitalization ratios from experience with the 2009 Minnesota FluLine nurse triage line. Assuming a 20% clinical attack rate and a case hospitalization rate of 0.8% to 1.5% (1968-like pandemic severity), we estimated the nationwide number of calls during the peak week of the pandemic to range from 1,551,882 to 3,523,902. Assuming a more severe 1957-like pandemic (case hospitalization rate = 1.5% to 3.0%), the national number of calls during the peak week of the pandemic ranged from 2,909,778 to 7,047,804. These results will aid in planning and developing nurse triage lines at both the national and state levels for use during a future influenza pandemic.

DOI: 10.1089/hs.2018.0061
PubMed: 30339099

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000213

Links to Exploration step

pubmed:30339099

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Estimating Weekly Call Volume to a National Nurse Telephone Triage Line in an Influenza Pandemic.</title>
<author><name sortKey="Adhikari, Bishwa B" sort="Adhikari, Bishwa B" uniqKey="Adhikari B" first="Bishwa B" last="Adhikari">Bishwa B. Adhikari</name>
<affiliation wicri:level="2"><nlm:affiliation>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge, TN. The authors are solely responsible for the content of this article; the views presented do not necessarily represent the official views of the Centers for Disease Control and Prevention. The authors have no conflicts of interest.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Koonin, Lisa M" sort="Koonin, Lisa M" uniqKey="Koonin L" first="Lisa M" last="Koonin">Lisa M. Koonin</name>
<affiliation wicri:level="2"><nlm:affiliation>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge, TN. The authors are solely responsible for the content of this article; the views presented do not necessarily represent the official views of the Centers for Disease Control and Prevention. The authors have no conflicts of interest.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Mugambi, Melissa L" sort="Mugambi, Melissa L" uniqKey="Mugambi M" first="Melissa L" last="Mugambi">Melissa L. Mugambi</name>
<affiliation wicri:level="2"><nlm:affiliation>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge, TN. The authors are solely responsible for the content of this article; the views presented do not necessarily represent the official views of the Centers for Disease Control and Prevention. The authors have no conflicts of interest.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Sliger, Kellye D" sort="Sliger, Kellye D" uniqKey="Sliger K" first="Kellye D" last="Sliger">Kellye D. Sliger</name>
<affiliation wicri:level="2"><nlm:affiliation>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge, TN. The authors are solely responsible for the content of this article; the views presented do not necessarily represent the official views of the Centers for Disease Control and Prevention. The authors have no conflicts of interest.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Washington, Michael L" sort="Washington, Michael L" uniqKey="Washington M" first="Michael L" last="Washington">Michael L. Washington</name>
<affiliation wicri:level="2"><nlm:affiliation>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge, TN. The authors are solely responsible for the content of this article; the views presented do not necessarily represent the official views of the Centers for Disease Control and Prevention. The authors have no conflicts of interest.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Kahn, Emily B" sort="Kahn, Emily B" uniqKey="Kahn E" first="Emily B" last="Kahn">Emily B. Kahn</name>
<affiliation wicri:level="2"><nlm:affiliation>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge, TN. The authors are solely responsible for the content of this article; the views presented do not necessarily represent the official views of the Centers for Disease Control and Prevention. The authors have no conflicts of interest.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Meltzer, Martin I" sort="Meltzer, Martin I" uniqKey="Meltzer M" first="Martin I" last="Meltzer">Martin I. Meltzer</name>
<affiliation wicri:level="2"><nlm:affiliation>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge, TN. The authors are solely responsible for the content of this article; the views presented do not necessarily represent the official views of the Centers for Disease Control and Prevention. The authors have no conflicts of interest.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="????"><PubDate><MedlineDate>2018 Sep/Oct</MedlineDate>
</PubDate>
</date>
<idno type="RBID">pubmed:30339099</idno>
<idno type="pmid">30339099</idno>
<idno type="doi">10.1089/hs.2018.0061</idno>
<idno type="wicri:Area/PubMed/Corpus">000213</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000213</idno>
<idno type="wicri:Area/PubMed/Curation">000213</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000213</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Estimating Weekly Call Volume to a National Nurse Telephone Triage Line in an Influenza Pandemic.</title>
<author><name sortKey="Adhikari, Bishwa B" sort="Adhikari, Bishwa B" uniqKey="Adhikari B" first="Bishwa B" last="Adhikari">Bishwa B. Adhikari</name>
<affiliation wicri:level="2"><nlm:affiliation>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge, TN. The authors are solely responsible for the content of this article; the views presented do not necessarily represent the official views of the Centers for Disease Control and Prevention. The authors have no conflicts of interest.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Koonin, Lisa M" sort="Koonin, Lisa M" uniqKey="Koonin L" first="Lisa M" last="Koonin">Lisa M. Koonin</name>
<affiliation wicri:level="2"><nlm:affiliation>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge, TN. The authors are solely responsible for the content of this article; the views presented do not necessarily represent the official views of the Centers for Disease Control and Prevention. The authors have no conflicts of interest.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Mugambi, Melissa L" sort="Mugambi, Melissa L" uniqKey="Mugambi M" first="Melissa L" last="Mugambi">Melissa L. Mugambi</name>
<affiliation wicri:level="2"><nlm:affiliation>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge, TN. The authors are solely responsible for the content of this article; the views presented do not necessarily represent the official views of the Centers for Disease Control and Prevention. The authors have no conflicts of interest.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Sliger, Kellye D" sort="Sliger, Kellye D" uniqKey="Sliger K" first="Kellye D" last="Sliger">Kellye D. Sliger</name>
<affiliation wicri:level="2"><nlm:affiliation>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge, TN. The authors are solely responsible for the content of this article; the views presented do not necessarily represent the official views of the Centers for Disease Control and Prevention. The authors have no conflicts of interest.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Washington, Michael L" sort="Washington, Michael L" uniqKey="Washington M" first="Michael L" last="Washington">Michael L. Washington</name>
<affiliation wicri:level="2"><nlm:affiliation>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge, TN. The authors are solely responsible for the content of this article; the views presented do not necessarily represent the official views of the Centers for Disease Control and Prevention. The authors have no conflicts of interest.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Kahn, Emily B" sort="Kahn, Emily B" uniqKey="Kahn E" first="Emily B" last="Kahn">Emily B. Kahn</name>
<affiliation wicri:level="2"><nlm:affiliation>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge, TN. The authors are solely responsible for the content of this article; the views presented do not necessarily represent the official views of the Centers for Disease Control and Prevention. The authors have no conflicts of interest.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Meltzer, Martin I" sort="Meltzer, Martin I" uniqKey="Meltzer M" first="Martin I" last="Meltzer">Martin I. Meltzer</name>
<affiliation wicri:level="2"><nlm:affiliation>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge, TN. The authors are solely responsible for the content of this article; the views presented do not necessarily represent the official views of the Centers for Disease Control and Prevention. The authors have no conflicts of interest.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Health security</title>
<idno type="eISSN">2326-5108</idno>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Humans</term>
<term>Influenza, Human (epidemiology)</term>
<term>Models, Statistical</term>
<term>Nurse's Role</term>
<term>Pandemics</term>
<term>Telephone (statistics & numerical data)</term>
<term>Triage (methods)</term>
<term>Triage (statistics & numerical data)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Grippe humaine (épidémiologie)</term>
<term>Humains</term>
<term>Modèles statistiques</term>
<term>Pandémies</term>
<term>Rôle de l'infirmier</term>
<term>Triage ()</term>
<term>Téléphone ()</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Triage</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Telephone</term>
<term>Triage</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Models, Statistical</term>
<term>Nurse's Role</term>
<term>Pandemics</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Humains</term>
<term>Modèles statistiques</term>
<term>Pandémies</term>
<term>Rôle de l'infirmier</term>
<term>Triage</term>
<term>Téléphone</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Telephone nurse triage lines, such as the Centers for Disease Control and Prevention's (CDC) Flu on Call<sup>®</sup>
, a national nurse triage line, may help reduce the surge in demand for health care during an influenza pandemic by triaging callers, providing advice about clinical care and information about the pandemic, and providing access to prescription antiviral medication. We developed a Call Volume Projection Tool to estimate national call volume to Flu on Call<sup>®</sup>
 during an influenza pandemic. The tool incorporates 2 influenza clinical attack rates (20% and 30%), 4 different levels of pandemic severity, and different initial "seed numbers" of cases (10 or 100), and it allows variation in which week the nurse triage line opens. The tool calculates call volume by using call-to-hospitalization ratios based on pandemic severity. We derived data on nurse triage line calls and call-to-hospitalization ratios from experience with the 2009 Minnesota FluLine nurse triage line. Assuming a 20% clinical attack rate and a case hospitalization rate of 0.8% to 1.5% (1968-like pandemic severity), we estimated the nationwide number of calls during the peak week of the pandemic to range from 1,551,882 to 3,523,902. Assuming a more severe 1957-like pandemic (case hospitalization rate = 1.5% to 3.0%), the national number of calls during the peak week of the pandemic ranged from 2,909,778 to 7,047,804. These results will aid in planning and developing nurse triage lines at both the national and state levels for use during a future influenza pandemic.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30339099</PMID>
<DateCompleted><Year>2019</Year>
<Month>02</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>02</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2326-5108</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>16</Volume>
<Issue>5</Issue>
<PubDate><MedlineDate>2018 Sep/Oct</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Health security</Title>
<ISOAbbreviation>Health Secur</ISOAbbreviation>
</Journal>
<ArticleTitle>Estimating Weekly Call Volume to a National Nurse Telephone Triage Line in an Influenza Pandemic.</ArticleTitle>
<Pagination><MedlinePgn>334-340</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1089/hs.2018.0061</ELocationID>
<Abstract><AbstractText>Telephone nurse triage lines, such as the Centers for Disease Control and Prevention's (CDC) Flu on Call<sup>®</sup>
, a national nurse triage line, may help reduce the surge in demand for health care during an influenza pandemic by triaging callers, providing advice about clinical care and information about the pandemic, and providing access to prescription antiviral medication. We developed a Call Volume Projection Tool to estimate national call volume to Flu on Call<sup>®</sup>
 during an influenza pandemic. The tool incorporates 2 influenza clinical attack rates (20% and 30%), 4 different levels of pandemic severity, and different initial "seed numbers" of cases (10 or 100), and it allows variation in which week the nurse triage line opens. The tool calculates call volume by using call-to-hospitalization ratios based on pandemic severity. We derived data on nurse triage line calls and call-to-hospitalization ratios from experience with the 2009 Minnesota FluLine nurse triage line. Assuming a 20% clinical attack rate and a case hospitalization rate of 0.8% to 1.5% (1968-like pandemic severity), we estimated the nationwide number of calls during the peak week of the pandemic to range from 1,551,882 to 3,523,902. Assuming a more severe 1957-like pandemic (case hospitalization rate = 1.5% to 3.0%), the national number of calls during the peak week of the pandemic ranged from 2,909,778 to 7,047,804. These results will aid in planning and developing nurse triage lines at both the national and state levels for use during a future influenza pandemic.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Adhikari</LastName>
<ForeName>Bishwa B</ForeName>
<Initials>BB</Initials>
<AffiliationInfo><Affiliation>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge, TN. The authors are solely responsible for the content of this article; the views presented do not necessarily represent the official views of the Centers for Disease Control and Prevention. The authors have no conflicts of interest.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Koonin</LastName>
<ForeName>Lisa M</ForeName>
<Initials>LM</Initials>
<AffiliationInfo><Affiliation>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge, TN. The authors are solely responsible for the content of this article; the views presented do not necessarily represent the official views of the Centers for Disease Control and Prevention. The authors have no conflicts of interest.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mugambi</LastName>
<ForeName>Melissa L</ForeName>
<Initials>ML</Initials>
<AffiliationInfo><Affiliation>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge, TN. The authors are solely responsible for the content of this article; the views presented do not necessarily represent the official views of the Centers for Disease Control and Prevention. The authors have no conflicts of interest.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sliger</LastName>
<ForeName>Kellye D</ForeName>
<Initials>KD</Initials>
<AffiliationInfo><Affiliation>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge, TN. The authors are solely responsible for the content of this article; the views presented do not necessarily represent the official views of the Centers for Disease Control and Prevention. The authors have no conflicts of interest.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Washington</LastName>
<ForeName>Michael L</ForeName>
<Initials>ML</Initials>
<AffiliationInfo><Affiliation>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge, TN. The authors are solely responsible for the content of this article; the views presented do not necessarily represent the official views of the Centers for Disease Control and Prevention. The authors have no conflicts of interest.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kahn</LastName>
<ForeName>Emily B</ForeName>
<Initials>EB</Initials>
<AffiliationInfo><Affiliation>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge, TN. The authors are solely responsible for the content of this article; the views presented do not necessarily represent the official views of the Centers for Disease Control and Prevention. The authors have no conflicts of interest.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Meltzer</LastName>
<ForeName>Martin I</ForeName>
<Initials>MI</Initials>
<AffiliationInfo><Affiliation>Bishwa B. Adhikari, PhD, is a Senior Economist; Michael L. Washington, PhD, is a Health Scientist; Emily B. Kahn, PhD, is a Senior Epidemiologist; and Martin I. Meltzer, PhD, is Senior Health Economist/Distinguished Consultant; all at the National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Lisa M. Koonin, DrPH, MN, MPH, is Deputy Director, Influenza Coordination Unit, National Center for Immunization & Respiratory Diseases, CDC, Atlanta. Melissa L. Mugambi, PhD, is Assistant Professor, Department of Global Health, University of Washington , Seattle, WA. Kellye D. Sliger, MPH, is an Epidemiologist, Oak Ridge Associated Universities, Oak Ridge, TN. The authors are solely responsible for the content of this article; the views presented do not necessarily represent the official views of the Centers for Disease Control and Prevention. The authors have no conflicts of interest.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>CC999999</GrantID>
<Agency>Intramural CDC HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Health Secur</MedlineTA>
<NlmUniqueID>101654694</NlmUniqueID>
<ISSNLinking>2326-5094</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D024802" MajorTopicYN="Y">Nurse's Role</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013689" MajorTopicYN="N">Telephone</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014218" MajorTopicYN="N">Triage</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Pandemic influenza</Keyword>
<Keyword MajorTopicYN="N">Public health preparedness/response</Keyword>
<Keyword MajorTopicYN="N">Telephone triage</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year>
<Month>10</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2018</Year>
<Month>10</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2019</Year>
<Month>2</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">30339099</ArticleId>
<ArticleId IdType="doi">10.1089/hs.2018.0061</ArticleId>
<ArticleId IdType="pmc">PMC6707072</ArticleId>
<ArticleId IdType="mid">NIHMS1006208</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Med Decis Making. 2006 Nov-Dec;26(6):617-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17099200</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2009 Jun 18;360(25):2595-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19423872</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Public Health Rep. 2012 Sep-Oct;127(5):532-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22942472</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2013 Jan;19(1):85-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23260039</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biosecur Bioterror. 2013 Mar;11(1):75-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23458098</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2015 May 1;60 Suppl 1:S1-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25878296</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000213 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000213 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:30339099
   |texte=   Estimating Weekly Call Volume to a National Nurse Telephone Triage Line in an Influenza Pandemic.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:30339099" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a PandemieGrippaleV1

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021

	Serveur d'exploration sur les pandémies grippales
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les pandémies grippales

Estimating Weekly Call Volume to a National Nurse Telephone Triage Line in an Influenza Pandemic.

Estimating Weekly Call Volume to a National Nurse Telephone Triage Line in an Influenza Pandemic.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki